Name | Title | Contact Details |
---|---|---|
Craig Smith |
Director of Information Technology | Profile |
MediBeacon was formed in 2012 specifically to acquire the optical diagnostic program from Mallinckrodt, the Pharmaceuticals business of Covidien. MediBeacon mission is to commercialize biocompatible optical diagnostic agents for physiological monitoring, surgical guidance, and imaging of pathological disease in the human population. Several product concepts in these arenas are contained in the MediBeacon Intellectual Property (IP) portfolio.
Creganna is a Minneapolis, MN-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Wasatch Microfluidics is a North Salt Lake, UT-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Biosystems of New England is a Waltham, MA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
StemCyte is a Covina, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.